期刊文献+

类风湿关节炎患者血清白细胞介素的检测及意义 被引量:3

Detection and significance of serum interleukins in patients with rheumatoid arthritis
下载PDF
导出
摘要 目的探讨白细胞介素(IL)-6、IL-17、IL-23及类风湿因子(RF)、C-反应蛋白(CRP)在类风湿关节炎(RA)患者发病中的作用。方法采用流式液相多重蛋白定量技术(CBA)检测60例活动期RA患者和32例健康对照组血清中IL-6、IL-17、IL-23的水平,采用免疫比浊法检测RF及CRP水平。结果活动期RA患者血清中IL-6、IL-17、IL-23、RF、CRP的水平高于健康对照组,差异具有统计学意义(P<0.05)。RF与IL-17呈正相关。不同年龄组的RA患者之间,IL-17水平差异有统计学意义(P<0.05)。结论 IL-6、IL-17、IL-23、RF及CRP在RA的发病过程中起着重要的作用,IL-17可能成为临床诊断的潜在候选指标之一。 Objective To explore the roles of IL-6,IL-17,IL-23,and C-reactive protein(CRP)in the nosogenesis of rheumatoid arthritis(RA).Methods Cytometric beads array(CBA)technology was used to detect the levels of IL-6,IL-17,IL-23 respectively in 60 cases of patients with active RA and 32 cases of healthy people(normal control group),and the levels of rheumatoid factor(RF)and CRP in the two groups were detected by immunoturbidimetric assay at the same time.Results The levels of IL-6,IL-17,IL-23,RF and CRP in serum of the active RA patients were significantly higher than those of normal control group(P〈0.05).The RF level was positive correlated with IL-17 level.The IL-17 levels of the RA patients were significantly different among different age groups(P〈0.05).Conclusion IL-6,IL-17,and IL-23 play important roles in the nosogenesis of RA,and IL-17 is expected to become one of the candidate marker for the diagnosis of RA.
出处 《检验医学与临床》 CAS 2015年第7期912-914,共3页 Laboratory Medicine and Clinic
基金 河北省承德市科技支撑计划项目(20132059)
关键词 类风湿关节炎 白细胞介素 类风湿因子 C-反应蛋白 rheumatoid arthritis interleukin rheumatoid factor C-reactive protein
  • 相关文献

参考文献16

  • 1Panayi GS. B cells:a fundamental role in the pathogenesis of rheumatoid arthritis? [J].Rheumatology (Oxford),2005,44(Suppl 2) :3-7.
  • 2Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the clas- sification of rheumatoid arthritis [J]. Arthritis Rheum, 1988,31 (3) : 315-324.
  • 3赵庆琪,姚加平.COPD患者血清IL-6、IL-8、hs-CRP和IL-18检测的临床意义[J].放射免疫学杂志,2012,25(4):404-406. 被引量:20
  • 4Woodrick RS,Ruderman EM. Interleukin 6 inhibition-RA and beyond[J]. Bull NYU Hosp J Dis,2010,69(3):225- 229.
  • 5Ju JH, Cho ML, Jhun JY, et al. Oral administration of type-II collagen suppresses IL-17-associated RANKL ex- pression of CD4+ T cells in collagen-induced arthritis[J]. Immunol Lett, 2008,117 ( 1 ) : 16-25.
  • 6Koenders MI, Lubberts E, Oppers-Walgreen B, et al. Bloc- king of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-l[J]. Am J Pathol, 2005,167(1) : 141-149.
  • 7Sehett G, Middleton S, Bolon B, et al. Additive bone-pro- tective effects of anabolic treatment when used in conjunc- tion with RANKL and tumor necrosis factor inhibition in two rat arthritis models[J]. Arthritis Rheum, 2005, 52 (5) : 1604-1611.
  • 8Koshy PJ, Henderson N, Logan C, et al. Interleukin 17 in- duces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory eytokines[J]. Ann Rheum Dis,2002,61(8) :704-713.
  • 9张颖健,赵金霞,孙琳,李常虹,李桂叶,刘湘源,栗占国.IgG IgA和IgM亚型抗环瓜氨酸肽抗体在早期类风湿关节炎中的检测及意义[J].中华风湿病学杂志,2013,17(1):5-9. 被引量:10
  • 10Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine,IL-23,with biologi- cal activities similar as well as distinct from IL-12[J]. Im- munity, 2000,13(5) : 715-725.

二级参考文献41

  • 1何浩明,郭继忠,朱习明,等主编.新编肺病防治必读[M].1版.上海:同济大学出版社,2006:71-73.
  • 2Pape H C, Van Griensven M, Rice J, et al. Major secondary surgery in blunt trauma patients and perioperative cytokine liberation: determination of the chnical relevance of biochemical marker [ J ]. J Trauma, 2011,50(6) :989-1000.
  • 3中华医学会呼吸病分会慢性阻塞病学组:慢性阻塞肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25():453-454.
  • 4Feldmann M, Brennau FM, Malni RN. Rheumatoid arthritis. Cell, 1996, 85: 307-310.
  • 5Schehekens GA, Visser H, de Jong BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum, 2000, 43: 155-163.
  • 6Quinn MA, Gough AK, Green MJ, et al. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology, 2006, 45: 478-480.
  • 7Ioan-Facsinay A, E1-Bannoudi H, Scherer HU, et al. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrulli- nated protein antibodies and contain overlapping and non-over- lapping reactivities. Ann Rheum Dis, 2011, 70: 188-193.
  • 8Arnett FC, Edworthy SM, Bloeh DA, et al. The American Rheumatism Association 1987 revised criteria for the classifica- tion of rheumatoid arthritis. Arthritis Rheum, 1988, 31: 315- 324.
  • 9Cohen S, Emery P. The American College of Rheumatology/European League against rheumatism criteria for the classification of rheumatoid arthritis: a game changer. Arthritis Rheum, 2010, 62 : 2592-2594.
  • 10Van der Linden MP, Knevel R, Huizinga TW, et al. Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology Criteria and the 2010 American College of Rheumatology/European League against Rheumatism Criteria. Arthritis Rheum, 2011, 63: 37-42.

共引文献43

同被引文献52

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部